Skip to main content

Key Product Details

Species Reactivity

Human

Applications

Western Blot, Immunoprecipitation

Label

Janelia Fluor 669

Antibody Source

Monoclonal Mouse IgG2B Clone # 236006

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Product Specifications

Immunogen

Mouse myeloma cell line NS0-derived recombinant human Kininogen
Gln19-Ser644 (Ile581Thr) (predicted)
Accession # P01042.2

Specificity

Detects human Kininogen Light Chain in direct ELISAs and Western blots. In Western blots, it reacts with the full length (amino acids 19‑644) and two forms of the light chain starting at amino acids 390 and 438, respectively, and does not react with the E. coli-expressed D5/Kininostatin. In Western blots, no cross-reactivity with recombinant human (rh) Cystatins A, B, C, D, E/M, F, S, SA, SN, rhFetuins A, B, rhHPRG, or recombinant mouse Kininogen is observed.

Clonality

Monoclonal

Host

Mouse

Isotype

IgG2B

Applications for Kininogen Antibody (236006) [Janelia Fluor® 669]

Application
Recommended Usage

Immunoprecipitation

Optimal dilutions of this antibody should be experimentally determined.

Western Blot

Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.

Formulation, Preparation, and Storage

Purification

Protein A or G purified from hybridoma culture supernatant

Formulation

50mM Sodium Borate

Preservative

0.05% Sodium Azide

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C in the dark.

Background: Kininogen

Kininogen, also known as 2-thiol proteinase inhibitor, is a multi-functional protein. The high molecule weight (HMW) form of kininogen is synthesized as a precursor protein (amino acid residues 1 to 644). The mature chain (residues 19 to 644) is further processed into the heavy chain (residues 19 to 380) and the light chain (residues 390 to 644) with release of the active peptide bradykinin. The heavy chain consists of three cystatin-like domains, which inhibit cysteine proteases. The light chain consists of a His-rich domain, which is associated with clotting activity.

Alternate Names

alpha 2-thiol Proteinase Inhibitor, BDK, KNG1

Gene Symbol

KNG1

Additional Kininogen Products

Product Documents for Kininogen Antibody (236006) [Janelia Fluor® 669]

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for Kininogen Antibody (236006) [Janelia Fluor® 669]



Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...